Corresponds to T90N mutation in human RRAGC implicated in follicular lymphoma; causes substantial reduction in Pho8Δ60 activity in quantitative Pho8Δ60 enzymatic assay, corresponding to elevated TOR activity
List of references used specifically to curate the information in Overview section.
Ying ZX, et al. (2016) Recurrent Mutations in the MTOR Regulator RRAGC in Follicular Lymphoma. Clin Cancer Res 22(21):5383-5393